From PaulDSPINE@aol.com Mon May 15 16:13:37 2000
Received: from mxu1.u.washington.edu (mxu1.u.washington.edu [140.142.32.8])
	by lists.u.washington.edu (8.9.3+UW00.05/8.9.3+UW99.09) with ESMTP id QAA52678
	for <physiatry@lists.u.washington.edu>; Mon, 15 May 2000 16:13:36 -0700
From: PaulDSPINE@aol.com
Received: from imo-d08.mx.aol.com (imo-d08.mx.aol.com [205.188.157.40])
	by mxu1.u.washington.edu (8.9.3+UW00.02/8.9.3+UW99.09) with ESMTP id QAA17204
	for <physiatry@u.washington.edu>; Mon, 15 May 2000 16:13:36 -0700
Received: from PaulDSPINE@aol.com
	by imo-d08.mx.aol.com (mail_out_v26.7.) id d.6a.2cf86ef (4261)
	 for <physiatry@u.washington.edu>; Mon, 15 May 2000 19:13:27 -0400 (EDT)
Message-ID: <6a.2cf86ef.2651de97@aol.com>
Date: Mon, 15 May 2000 19:13:27 EDT
Subject: Re: information on Vax-D treatment
To: physiatry@u.washington.edu
MIME-Version: 1.0
Content-Type: text/plain; charset="US-ASCII"
Content-Transfer-Encoding: 7bit
X-Mailer: AOL 5.0 for Windows sub 104

go to http://www.vaxd.net/research.htm

A patient brought this to me. There are three research papers here to review.

Paul Dreyfuss
.